MyGlo. Now You Can.
Meet the pioneers of possibilities who are using MyGlo® to work faster, more reliably, and with greater confidence across biotech startups, academic labs, and research institutions.
Videos
With MyGlo, Professor Rachel Simmonds' lab at the University of Surrey can now read live cell assays directly in their biosafety cabinet in a high containment laboratory—accelerating research into how macrophages contribute to Buruli ulcer virulence.
Articles
Go Faster From Idea To Insights
MyGlo® helps the University of Cincinnati's Phoenix Lab advance their research for pediatric brain cancer by cutting plate read time and reducing contamination risk.
“I’ve never been happier with a piece of technology”
- Ipsita Kundu
Focus On Discovery Not The Device
Rebecca Miles, PhD teaches her undergraduate Taylor University Students real world skills and research methods with help from MyGlo® and the easy to use ProNect® apps.
"I like the small size and the portability"
- Rebecca Miles
Work Anywhere Your Science Takes You
Tridek-One takes MyGlo® on the road to accelerate discovery of immunomodulating treatments even outside the lab.
"You could not have built a better thing"
- Guillame Even
Trust Your Data, Every Time
Grove Biopharma leverages the reliability, seamless workflow, and convenience of MyGlo® and ProNect® apps to accelerate drug discovery within this growing biotech company.
The team described MyGlo® as user friendly, consistent, and “always working”.
MyGlo Arrives At University of Ghent
Click on the picture to check out the post in LinkedIn.
Validating Screening Hits with MyGlo
Dr. Ed Feris no longer waits for time on a shared instrument. MyGlo lets him read stacks of plates in less than half the time, with results that match or exceed what he was getting before.
“The bleed over was definitely a big improvement over the SpectraMax®”
- Dr. Feris
White Papers
MyGlo® Reagent Reader Enables Fast, Sensitive Platelet Activation Assay
Tridek-One Therapeutics adapted the RealTime-Glo™ Extracellular ATP Assay for endpoint detection of platelet activation in human whole blood. Using the MyGlo® Reagent Reader enabled sensitive ATP detection comparable to multimode readers in under 30 seconds. This workflow provides a scalable platform for screening compounds that modulate platelet activity.
© 2026 Promega Corporation. All Rights Reserved.
Need Assistance?